Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome

NCT00057031 is registered in ClinicalTrials.gov with Novacea as lead sponsor.

NCT NCT00057031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00057031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome
Lead sponsor
Novacea
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2002
Completion date
March 31, 2004
Enrollment
46
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome